RG 7906Alternative Names: RG7906
Latest Information Update: 11 Feb 2017
At a glance
- Originator Roche
- Class Antipsychotics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Psychiatric disorders
Most Recent Events
- 31 Mar 2016 Phase-I clinical trials in Psychiatric disorders (In volunteers) (unspecified route) (Roche presentation, July 2016)